Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

MaryAnn M Murakami

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Clinical Cornerstone|May 19, 2005
The diagnostic utility of cardiac biomarkers in detecting myocardial infarctionFred S Apple, MaryAnn M Murakami
Clinical Chemistry|September 18, 2012
Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy populationFred S Apple, Ranka Ler, MaryAnn M Murakami
Clinical Biochemistry|July 16, 2013
Diagnostic performance of four point of care cardiac troponin I assays to rule in and rule out acute myocardial infarctionVikram Palamalai, MaryAnn M Murakami, Fred S Apple
Archives of Pathology & Laboratory Medicine|March 27, 2004
Diagnostic and prognostic value of cardiac troponin I assays in patients admitted with symptoms suggestive of acute coronary syndromeFred S Apple, Heidi E Quist, MaryAnn M Murakami
Clinical Biochemistry|June 1, 2010
Defining the serum 99th percentile in a normal reference population measured by a high-sensitivity cardiac troponin I assayFred S Apple, Peter A Simpson, Maryann M Murakami
Clinical Chemistry|December 13, 2003
Rates of positive cardiac troponin I and creatine kinase MB mass among patients hospitalized for suspected acute coronary syndromesJoseph C Lin, Fred S Apple, MaryAnn M Murakami, et al.
Clinical Chemistry|October 11, 2008
Analytical characteristics of commercial cardiac troponin I and T immunoassays in serum from rats, dogs, and monkeys with induced acute myocardial injuryFred S Apple, MaryAnn M Murakami, Ranka Ler, et al.
Clinical Biochemistry|April 3, 2012
Delta changes for optimizing clinical specificity and 60-day risk of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome utilizing the ADVIA Centaur TnI-Ultra assayFred S Apple, Stephen W Smith, Lesly A Pearce, et al.
Clinical Chemistry|November 26, 2008
Assessment of the multiple-biomarker approach for diagnosis of myocardial infarction in patients presenting with symptoms suggestive of acute coronary syndromeFred S Apple, Stephen W Smith, Lesly A Pearce, et al.
Clinical Chemistry|September 15, 2004
Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause deathFred S Apple, Maryann M Murakami, Lesly A Pearce, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Clinical Cornerstone|May 19, 2005
The diagnostic utility of cardiac biomarkers in detecting myocardial infarctionFred S Apple, MaryAnn M Murakami
Clinical Chemistry|September 18, 2012
Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy populationFred S Apple, Ranka Ler, MaryAnn M Murakami
Clinical Biochemistry|July 16, 2013
Diagnostic performance of four point of care cardiac troponin I assays to rule in and rule out acute myocardial infarctionVikram Palamalai, MaryAnn M Murakami, Fred S Apple
Archives of Pathology & Laboratory Medicine|March 27, 2004
Diagnostic and prognostic value of cardiac troponin I assays in patients admitted with symptoms suggestive of acute coronary syndromeFred S Apple, Heidi E Quist, MaryAnn M Murakami
Clinical Biochemistry|June 1, 2010
Defining the serum 99th percentile in a normal reference population measured by a high-sensitivity cardiac troponin I assayFred S Apple, Peter A Simpson, Maryann M Murakami
Clinical Chemistry|December 13, 2003
Rates of positive cardiac troponin I and creatine kinase MB mass among patients hospitalized for suspected acute coronary syndromesJoseph C Lin, Fred S Apple, MaryAnn M Murakami, et al.
Clinical Chemistry|October 11, 2008
Analytical characteristics of commercial cardiac troponin I and T immunoassays in serum from rats, dogs, and monkeys with induced acute myocardial injuryFred S Apple, MaryAnn M Murakami, Ranka Ler, et al.
Clinical Biochemistry|April 3, 2012
Delta changes for optimizing clinical specificity and 60-day risk of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome utilizing the ADVIA Centaur TnI-Ultra assayFred S Apple, Stephen W Smith, Lesly A Pearce, et al.
Clinical Chemistry|November 26, 2008
Assessment of the multiple-biomarker approach for diagnosis of myocardial infarction in patients presenting with symptoms suggestive of acute coronary syndromeFred S Apple, Stephen W Smith, Lesly A Pearce, et al.
Clinical Chemistry|September 15, 2004
Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause deathFred S Apple, Maryann M Murakami, Lesly A Pearce, et al.
Pageof 4